Skip to content
-
Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees
Jul 29, 2020
WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
-
NASP Submits Comments to CMS
Jul 23, 2020
WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
-
NASP Member EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments
Jul 23, 2020
EVERSANA, the leading provider of global commercial services to the life sciences industry, today announced a partnership with ICER to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. read more
-
NASP submits comments to CMS on CMS-284-P
Jul 20, 2020
NASP submitted recommendations on sections of the rule to specifically address the needs of specialty patients and the pharmacies that serve their needs. read more
-
The State of Specialty Pharmacy 2020
Jul 01, 2020
read more
-
Nationwide Children’s Hospital Specialty Pharmacy is NASP’s July Corporate Member of the Month
Jul 01, 2020
Our Corporate Member of the Month, Nationwide Children’s Hospital Specialty Pharmacy, defines success as “seeing our... read more
-
Specialty Pharmacists Report: Patient’s Treatment Delays can be Avoided
Jun 15, 2020
read more
-
NASP announces the 2020 Annual Meeting & Expo VIRTUAL EXPERIENCE!
Jun 12, 2020
Utilizing innovation and cutting-edge technology, the NASP Annual Meeting Virtual Experience allows you to learn, share, foster partnerships, and earn CPE credits from the safety and comfort of your home or office. read more
-
NASP submits comments to CMS on CMS-1744-IFC
Jun 01, 2020
WASHINGTON, DC (June 1, 2020) – Please click here to read NASP’s comments submitted Monday, June... read more
-
There’s No Going Back – Virtual Patient Support is Here to Stay
May 26, 2020
read more